| 5-HTOL | 5-hydroxytryptophol |
| α-SMA | α smooth muscle actin |
| ACC | adiponectin and acetyl-CoA carboxylase |
| ACLF | acute-on-chronic liver failure |
| ADH | alcohol dehydrogenase |
| AFL | alcoholic fatty liver |
| AFRI | acoustic radiation force impulse |
| AH | alcoholic hepatitis |
| ALD | alcohol-related liver disease |
| ALDH | aldehyde dehydrogenase |
| ALT | alanine aminotransferase |
| AMPK | AMP-activated protein kinase |
| APRI | aspartate aminotransferase to platelet ratio index |
| ASK-1 | apoptosis signal regulating kinase-1 |
| AST | aspartate aminotransferase |
| AUD | alcohol use disorder |
| AWS | alcohol withdrawal syndrome |
| Btg2 | b-cell translocation gene 2 |
| CAP | controlled attenuation parameter |
| CCl4 | carbon tetrachloride |
| CCL20 | C-C motif chemokine ligand 20 |
| CDT | carbohydrate deficient transferrin |
| C/EBPβ | CCAAT/enhancer-binding protein β |
| CK-18 | cytokeratin-18 |
| CK-19 | cytokeratin-19 |
| CXCL1 | C-X-C motif chemokine ligand 1 |
| CYP2E1 | cytochrome P450 2E1 |
| DAMPs | damage-associated molecular patterns |
| DR5 | death receptor 5 |
| DUSP | dual specificity phosphatase |
| EASL | European association for the study of the liver |
| Egr-1 | early growth response protein 1 |
| ELF | enhanced liver fibrosis |
| ET-1 | endothelin-1 |
| EtG | ethyl glucuronide |
| EtS | ethyl sulfate |
| FAEEs | fatty acid ethyl esters |
| FASLG | fas ligand |
| FIB-4 | fibrosis-4 |
| FMT | fecal microbiota transplantation |
| FXR | farnesoid X receptor |
| GABA-B | gamma-aminobutyric acid-B |
| G-CSF | granulocyte-colony stimulating factor |
| GSR | glutathione reductase |
| GWAS | genome-wide association studies |
| HA | hyaluronic acid |
| HCC | hepatocellular carcinoma |
| HIF-1α | hypoxia inducible factor 1α |
| HIV | human immunodeficiency virus |
| HSCs | hepatic stellate cells |
| HSD17B13 | hydroxysteroid 17-β dehydrogenase 13 |
| IL | interleukin |
| LPS | lipopolysaccharide |
| LT | liver transplantation |
| MBOAT7 | membrane-bound O-acyltransferase domain-containing protein 7 |
| MeCP2 | methyl-CPG binding protein 2 |
| MEOS | microsomal ethanol-oxidizing system |
| miRNA | microRNA |
| MMP | matrix metalloproteinases |
| MSCs | mesenchymal stem cells |
| NAC | N-acetylcysteine |
| nAChR | nicotinic acetylcholine receptors |
| NAD | nicotinamide adenine dinucleotide |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NMDA | N-methyl-d-aspartate |
| Nrf-2 | nuclear factor erythroid 2-related factor 2 |
| PICP | type I procollagen carboxypropeptide |
| PINP | type I procollagen aminopropeptide |
| PIIINP | type III procollagen aminopropeptide |
| PEth | phosphatidylethanol |
| PDGF | platelet-derived growth factor |
| Phox | phagocytic oxidase |
| PI3K | phosphoinositide 3-kinase |
| PIGF | placenta growth factor |
| PNPLA3 | patatin-like phospholipase domain-containing-3 |
| POR | cytochrome P450 oxidoreductase |
| PPARα | peroxisome proliferator activated receptor α |
| PTX | pentoxifylline |
| RCT | randomized controlled trial |
| ROS | reactive oxygen species |
| SAM | s-adenosylmethionine |
| SIRT1 | sirtuin 1 |
| STAT3 | signal transducer and activator of transcription 3 |
| SSRI | selective serotonin reuptake inhibitors |
| SWE | shear-wave elastography |
| TE | transient elastography |
| TfR1 | transferrin receptor 1 |
| TGF-β | transforming growth factor β |
| TGFβRII | type II transforming growth factor-β receptor |
| TIMPs | tissue inhibitor of metalloproteinases |
| TLRs | toll-like receptors |
| TM6SF2 | transmembrane 6 superfamily member 2 |
| TNF-α | tumor necrosis factor α |
| VEGF | vascular endothelial growth factor |
| WHO | world health organization |
| Yy1 | yin yang 1 |
| ZEB2 | zinc finger E-box binding homeobox 2 |
| ZO-1 | zonula occludens 1 |